Sally Hopewell

My key areas of research expertise are in the design, conduct and transparent reporting of randomized trials and systematic reviews. I have published a number of research studies in these areas including the development of key reporting guidelines such as the CONSORT Statement and PRISMA for Abstracts.

I joined OCTRU in February 2015, where I am involved in leading the design and delivery of clinical trials within the OCTRU portfolio. I am co-chief investigator on several NIHR funded trials for interventions for people with shoulder pain and impaired shoulder function and co-investigator on a number of other NIHR funded trials and evidence syntheses.

Previously, I worked at the Centre for Statistics in Medicine (2007 – 2015) on an MRC-funded programme of research related to CONSORT and the conduct and reporting of clinical trials. I also worked, and continue to collaborate with, the Centre d’Epidemiologie Clinique (2012 – present), University Paris Descartes, on research activities related to the methodology of systematic reviews and randomized trials.

Prior to this I worked at the UK Cochrane Centre (2004 – 2012) and with the NHS National Blood Service (2010 – 2012) systematic review programme. In 2005, I was awarded a D.Phil at the University of Oxford on research into the effects of unpublished data in systematic reviews.

I have a particular interest in clinical trial registration, data sharing, transparent reporting of trial protocols, development of core outcome sets, pilot trials and trials of complex interventions. I am a member of the advisory board for Current Controlled Trials, a member of the NIHR Health Technology Assessment Clinical Evaluation and Trials Board and member of the NIHR Open Research Advisory Board. I regularly carry out peer review for high impact medical journals and various funding bodies (e.g. NIHR and Medical Research Council).